Clinical Trial Update: BIOSILITACE AS A DESENSITIZING AGENTIN HMI [NA]

View source ↗

Summary

Clinical trial update for BIOSILITACE as a desensitizing agent in dentin hypersensitivity and molar-incisor hypomineralization, status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dentin Hypersensitivity
• Molar-incisor Hypomineralization

Drugs mentioned

• BIOSILITACE

Snippet

Sponsor: University of Sao Paulo | Conditions: Sensitive Dentin, Hypomineralization Molar Incisor | NA | Status: NOT_YET_RECRUITING